206 related articles for article (PubMed ID: 11188938)
1. [Detection of minimal residual disease in acute leukemias by flow cytometry].
Scolnik MP
Medicina (B Aires); 2000; 60 Suppl 2():83-6. PubMed ID: 11188938
[TBL] [Abstract][Full Text] [Related]
2. [Immunophenotyping in acute leukemia: detection of minimal residual disease].
Pálóczi K; Nahajevszky S; Jakab K; Regéczy N; Gopcsa L; László E; Földi J
Orv Hetil; 2000 Nov; 141(46):2487-92. PubMed ID: 11126681
[TBL] [Abstract][Full Text] [Related]
3. Leukemia-associated phenotypes: their characteristics and incidence in acute leukemia.
Babusíková O; Glasová M; Koníková E; Kusenda J
Neoplasma; 1996; 43(6):367-72. PubMed ID: 8996560
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric determination of leukemia-associated marker combinations for the study of minimal residual disease.
Babusíková O; Glasová M; Kusenda J; Koníková E; Mésárosová A
Neoplasma; 1994; 41(6):305-13. PubMed ID: 7870213
[TBL] [Abstract][Full Text] [Related]
5. Multiparametric analysis of normal and postchemotherapy bone marrow: Implication for the detection of leukemia-associated immunophenotypes.
Olaru D; Campos L; Flandrin P; Nadal N; Duval A; Chautard S; Guyotat D
Cytometry B Clin Cytom; 2008 Jan; 74(1):17-24. PubMed ID: 18061947
[TBL] [Abstract][Full Text] [Related]
6. [Minimal residual disease in childhood acute leukemias].
Pawińska K; Balwierz W; Baran J
Przegl Lek; 2006; 63(1):41-3. PubMed ID: 16892899
[TBL] [Abstract][Full Text] [Related]
7. [Immunophenotyping of acute leukemias: diagnostic and pronostic utility in Abidjan, Côte d'Ivoire].
Inwoley KA; Sawadogo D; Mizero L; Salou M; Karim N; Sangaré A
Bull Soc Pathol Exot; 2004; 97(5):319-22. PubMed ID: 15787262
[TBL] [Abstract][Full Text] [Related]
8. Impact of immunophenotyping on management of acute leukemias.
Béné MC; Bernier M; Castoldi G; Faure GC; Knapp W; Ludwig WD; Matutes E; Orfao A; van't Veer M
Haematologica; 1999 Nov; 84(11):1024-34. PubMed ID: 10553164
[TBL] [Abstract][Full Text] [Related]
9. Significance of FCM-DNA measurement in detecting minimal residual disease in leukemia.
Zhang RX; Yao EG
Chin Med J (Engl); 1990 Oct; 103(10):826-30. PubMed ID: 2125256
[TBL] [Abstract][Full Text] [Related]
10. Multiparametric flow cytometry in detection of minimal residual disease in acute lymphoblastic leukemia of early B-cell phenotype.
Mlcáková A; Babusíková O
Neoplasma; 2003; 50(6):416-21. PubMed ID: 14689062
[TBL] [Abstract][Full Text] [Related]
11. Detection of minimal residual disease in unselected patients with acute myeloid leukemia using multiparameter flow cytometry for definition of leukemia-associated immunophenotypes and determination of their frequencies in normal bone marrow.
Kern W; Danhauser-Riedl S; Ratei R; Schnittger S; Schoch C; Kolb HJ; Ludwig WD; Hiddemann W; Haferlach T
Haematologica; 2003 Jun; 88(6):646-53. PubMed ID: 12801840
[TBL] [Abstract][Full Text] [Related]
12. Advances in the immunological monitoring of childhood acute lymphoblastic leukaemia.
Campana D; Coustan-Smith E
Best Pract Res Clin Haematol; 2002 Mar; 15(1):1-19. PubMed ID: 11987913
[TBL] [Abstract][Full Text] [Related]
13. Modern diagnostics in acute leukemias.
Haferlach T; Kern W; Schnittger S; Schoch C
Crit Rev Oncol Hematol; 2005 Nov; 56(2):223-34. PubMed ID: 16213152
[TBL] [Abstract][Full Text] [Related]
14. PCR detection of clonal IgH and TCR gene rearrangements at the end of induction as a non-remission criterion in children with ALL: comparison with standard morphologic analysis and risk group classification.
Scrideli CA; Queiroz RG; Bernardes JE; Valera ET; Tone LG
Med Pediatr Oncol; 2003 Jul; 41(1):10-6. PubMed ID: 12764736
[TBL] [Abstract][Full Text] [Related]
15. [Clinical significance and prognostic detection of minimal residual disease in acute leukemias].
Deptała A; Widzyńska I; Kuratowska Z
Acta Haematol Pol; 1995; 26(4):413-20. PubMed ID: 8571743
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of immunophenotype and leukemia associated immunophenotype in 610 patients with acute myeloid leukemia].
Liu YR; Wang YZ; Chen SS; Chang Y; Fu JY; Li LD; Wang H; Yu H; Jiang B; Huang XJ
Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):731-6. PubMed ID: 18457262
[TBL] [Abstract][Full Text] [Related]
17. Detection of minimal residual disease in acute leukemia.
van der Velden VH; Boeckx N; van Wering ER; van Dongen JJ
J Biol Regul Homeost Agents; 2004; 18(2):146-54. PubMed ID: 15471219
[TBL] [Abstract][Full Text] [Related]
18. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia.
Zeleznikova T; Stevulova L; Kovarikova A; Babusikova O
Neoplasma; 2007; 54(6):471-7. PubMed ID: 17949229
[TBL] [Abstract][Full Text] [Related]
19. Stability of leukemia-associated aberrant immunophenotypes in patients with acute myeloid leukemia between diagnosis and relapse: comparison with cytomorphologic, cytogenetic, and molecular genetic findings.
Voskova D; Schoch C; Schnittger S; Hiddemann W; Haferlach T; Kern W
Cytometry B Clin Cytom; 2004 Nov; 62(1):25-38. PubMed ID: 15468339
[TBL] [Abstract][Full Text] [Related]
20. [Importance of the detection of minimal residual disease in the management of acute leukemia].
Mód A; Tamáska J; Adám E; Gidáll J; Poros A; Király A; Natonek K; Pálóczi K; Hollán Z
Orv Hetil; 1991 Jun; 132(24):1291-6, 1299. PubMed ID: 1857605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]